Pecot MALDI MS signature + clinical and imaging data
A serum proteomic signature of seven features identified by MALDI MS was previously identified (see "Yildiz MALDI MS signature for lung cancer"). The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels. Here the signature is applied to cohorts presenting with one or more lung nodules discovered by clinical evaluation and chest CT.
No member markers defined for this panel.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
This blood biomarker signature may add value to the clinical and chest CT evaluation of indeterminate lung nodules.
No associated resources found.